Additional Risk Minimisation Measures for Medicinal Products in the European Union: A Review of the Implementation and Effectiveness of Measures in the United Kingdom by One Marketing Authorisation Holder
Crossref DOI link: https://doi.org/10.1007/s40290-017-0184-8
Published Online: 2017-03-29
Published Print: 2017-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Agyemang, Elaine http://orcid.org/0000-0003-1061-8253
Bailey, Lorna
Talbot, John
Funding for this research was provided by:
F. Hoffmann-La Roche
License valid from 2017-03-29